Profile
Doctorate-level pharmacist with more than 25 years of experience in product development. Specialised in combining pharmaceutical quality with modern microbiome research.
Career and background
Dr. Hari Sven Krishnan is a pharmacist with a doctorate and one of the driving forces behind Heilpflanzenwohl: as CEO and Chairman of the Board of Directors of Heilpflanzenwohl AG he leads the company and brings the pharmaceutical perspective to the Medical Advisory Board.
He studied pharmacy in Frankfurt and earned his doctorate at Humboldt University in Berlin. After three years as a consultant at McKinsey he joined Novartis in 2002, where he held responsibilities in sales in the USA, as CEO in Denmark and Russia and as marketing director in Germany. From 2012 he headed SevenVentures at ProSiebenSat.1 and later became its Chief Operating Officer, before founding Heilpflanzenwohl.
Areas of expertise
- Product development
- Pharmaceutical quality
- Microbiome research
Additional role
CEO and Chairman of the Board of Directors, Heilpflanzenwohl AG
